Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study. [electronic resource] by
- Spencer, Andrew
- Roberts, Andrew
- Kennedy, Nola
- Ravera, Christina
- Cremers, Serge
- Bilic, Sanela
- Neeman, Terry
- Copeman, Michael
- Schran, Horst
- Lynch, Kevin
Producer: 20080709
In:
BMC clinical pharmacology vol. 8
Availability: No items available.
|
|
9.
|
|
|
10.
|
The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit. [electronic resource] by
- Harrison, Simon J
- Quach, Hang
- Link, Emma
- Feng, Huaibao
- Dean, Joanne
- Copeman, Michael
- Van De Velde, Helgi
- Schwarer, Anthony
- Baker, Bartrum
- Spencer, Andrew
- Catalano, John
- Campbell, Philip
- Augustson, Bradley
- Romeril, Ken
- Prince, Henry Miles
Producer: 20150623
In:
American journal of hematology vol. 90
Availability: No items available.
|